Search

everythinglearnresearchcommunity

for

Search:↓

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Both treatments promote hair growth safely, but stem cells are slightly more effective.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Tirzepatide may improve hair loss by reducing insulin resistance.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Cronkhite-Canada syndrome can be diagnosed without gastrointestinal polyps if there is severe mucosal atrophy and edema.

Negative pressure fractional microneedle radiofrequency effectively and safely reduces periorbital aging signs.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Tofacitinib treatment for hair loss may worsen acne.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

Vitamin D might help treat some types of hair loss, but more research is needed.

Ayurvedic treatment successfully regrew hair in a 19-year-old with alopecia areata in 2 months.

Using both topical and oral minoxidil doesn't significantly reduce temporary hair shedding.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.